 |
Nitric oxide |
|---|---|
| Trade Name | Inomax |
| Orphan Indication | To reduce the risk of chronic lung disease in premature neonates |
| USA Market Approval | USA |
| USA Designation Date | 2004-09-27 00:00:00 |
| Sponsor | Mallinckrodt Hospital Products;1425 U.S. 206;Bedminster Township, New Jersey, 07921 |
